ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2026
Perspective on human diagnostic and national reference laboratory preparedness for zoonotic influenza in Europe.
Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Zoonotic influenza A viruses (zIAV) originating from avian and swine reservoirs present a serious concern for public health. Since the emergence of zIAV A(H5N1) in 1996, the virus has spread globally, impacting wild birds, poultry, wild and domestic mammals, including cattle and pigs, and sporadically infecting humans. Challenges persist in detecting and characterising zIAV, particularly at the human-animal interface. Recent external quality assessments conducted in the Netherlands and at European level have evaluated the capacity of human clinical diagnostic and national reference laboratories to detect, subtype and characterise potential zIAV. Based on these results, we reflect on the status and challenges of methods used for identifying cases of zIAV infection in Europe. While all laboratories are largely successful in generic detection of influenza A virus, subtyping is not widely used in clinical diagnostic laboratories. For national reference laboratories, subtyping specifically of swine-origin viruses remains challenging, often requiring sequencing for accurate identification. Although sequencing offers greater potential for characterising zIAV, training in the appropriate use of bioinformatics tools is needed. Raising awareness among healthcare professionals to document animal exposure in patient disease histories is also critical, as early suspicion of zoonotic infections is needed to direct laboratory testing, including subtyping.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.